Finished-formulation license
A defined product package with evidence, specifications and commercialization rights.
Flexible commercial structures for fields, territories, formulations, finished products, platform components and development-stage assets.
Flexible commercial structures for fields, territories, formulations, finished products, platform components and development-stage assets.
Specific terms depend on evidence, scope, exclusivity, territory, development obligations, supply and strategic fit.
ChronoSense® connects the biological hypothesis to delivery, evidence, data and a controlled route to market.
A defined product package with evidence, specifications and commercialization rights.
Rights aligned to a specific use, application or professional channel.
Geographic commercialization rights with agreed development and launch obligations.
Partner-led brand commercialization within approved specifications and claims.
Shared generation of formulation, evidence, digital or pharmaceutical assets.
Economics designed to fund value-inflecting work and align long-term outcomes.
The platform is designed to move through explicit stages, with evidence and access appropriate to each one.
Clarify market, application, route, territory and commercial objective.
Use staged access to examine scientific, technical and supply readiness.
Set responsibilities, milestones, costs, claims and go/no-go decisions.
Transfer, launch and improve under quality and brand governance.
A structured brief helps DeepSense assess scope, rights, responsibilities and evidence before terms are discussed.